Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

8.720 USD -0.080 (-0.91%)
Official Closing Price Updated: 7:59 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Inovio Pharma

< Previous 1 2
...
70 71 72 73 74 75 76 77 Next >
Critical Alerts For General Electric, Inovio Pharmaceuticals, Mylan, Rite Aid and Delta Airlines Released By InvestorsObserver
From PR Newswire
The bottom of a capitulation barrel and the test tubes that say keep buying
NEED TO KNOW: Capitulation bottom, that’s what some are calling this, plus worry about the Russell and five test tubes that tell investors to keep buying stocks. 
Tags Company Announcements Medical Products Software
From MarketWatch
Inovio CEO: New Ebola vaccine effective in animals
An Ebola vaccine in development has shown preliminary success in beating back the deadly virus, Inovio CEO Joseph Kim says. 
Tags Inovio Biomedical Corporation tvcodes/tvfloor Investing/Stock Market
From CNBC.com News
Ebola vaccine: Why it's taking so long to make one
Efforts to develop an Ebola vaccine have been in the works for some time. But experts say it's unlikely to see one available anytime soon. 
Tags Health Care/Pharmaceuticals Biotechnology and Life Sciences Health Care tvcodes/tvnn
From CNBC.com News
Inovio Pharmaceuticals Appoints Vice President of Commercial Development
New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble 
From PR Newswire
RPT-Scientists grapple with ethics in rush to release Ebola vaccines
* Ebola emergency demands speed, more risk in vaccine tests 
Tags companyNews
From Reuters: Company News
Scientists grapple with ethics in rush to release Ebola vaccines
* Ebola emergency demands speed, more risk in vaccine tests 
Tags companyNews
From Reuters: Company News
Inovio Biomedical Up on Heavy Volume in Possible Trend Reversal (INO)
From Comtex SmarTrend® News Briefs
Inovio Pharma Wants To Join The Ebola Party
Inovio Pharmaceuticals To Begin Ebola Vaccine Study in early 2015 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Inovio Biomedical Crosses Above its 10-day MA (INO)
From Comtex SmarTrend® News Briefs
Inovio, GeneOne to move Ebola vaccine to human trials
Companies plan to start Phase I clinical trial in first half of 2015. 
Tags UK:GSK JNJ Health/Care
From MarketWatch
Inovio to start human trials of Ebola vaccine
Sept 24 (Reuters) - Vaccine developer Inovio Pharmaceuticals Inc said the company and its partner GeneOne Life Science Inc will start testing its experimental Ebola vaccine in humans in the first half... 
Tags companyNews
From Reuters: Company News
Morning Market Movers
Lipocine (NASDAQ: LPCN) shares gained 76.44% to $9.21 after the company reported positive top-line results in its Phase 3 study of LPCN ... 
Tags ELMD INO News
From Benzinga
US Stock Futures Up Ahead Of New Home Sales Report
Pre-open movers US stock futures traded higher in early pre-market trade. Data on new home sales for August will be released at 10:00 ... 
Tags News INO Futures
From Benzinga
Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science
From PR Newswire
Inovio Pharmaceuticals Expands HPV Immunotherapy Development To Aerodigestive Cancers
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today it has initiated a phase I clinical trial in patients with aerodigestive ... 
Tags INO Press Releases News
From Benzinga
Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
Expansion Comes After Successful Phase II Trial for Cervical Dysplasia 
From PR Newswire
Inovio to Present at Upcoming Investor Conferences
From PR Newswire
Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange
From PR Newswire
Lightning Round: Wendy's, ImmunoGen & more
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. 
Tags North Atlantic Drilling Ltd Investing/Stock Market/Stock Picks Mad Money for Mobile
From CNBC.com News
Inovio Pharmaceuticals to List on NASDAQ
From PR Newswire
Inovio to Present at Upcoming Investor Conferences
From PR Newswire
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
5 Companies Developing New Cancer Drugs
The search for a cure for cancer has consumed the public discourse around the world and the United States for as long as one can ... 
Tags INO Health Care General
From Benzinga
Inovio Biomedical Crosses Above its 10-day MA (INO)
From Comtex SmarTrend® News Briefs
Wednesday 8/13 Insider Buying Report: INO, PDI
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... 
Tags Stocks
From Market News Video
Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
HPV Immune Therapy VGX-3100 to Advance into Phase III 
From PR Newswire
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuti
From PR Newswire
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
From PR Newswire
23.2% Return Seen to Date on SmarTrend Inovio Biomedical Call (INO)
From Comtex SmarTrend® News Briefs
< Previous 1 2
...
70 71 72 73 74 75 76 77 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.